(Q43524242)

English

Performance of ProEx C and PreTect HPV-Proofer E6/E7 mRNA tests in comparison with the hybrid capture 2 HPV DNA test for triaging ASCUS and LSIL cytology

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Performance of ProEx C and PreTect HPV-Proofer E6/E7 mRNA tests in comparison with the hybrid capture 2 HPV DNA test for triaging ASCUS and LSIL cytology (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

François Coutlée

7

object named as

Francois Coutlee

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Reza Alaghehbandan

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Daniel Fontaine

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

James Bentley

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Nicholas Escott

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Prafull Ghatage

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Adrian Lear

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Samuel Ratnam

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

22 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Diagnostic Cytopathology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

767-775

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology.

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

MOLECULAR MARKERS OF EARLY CERVICAL NEOPLASIA.

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Detecting high-grade cervical disease on ASC-H cytology: role of BD ProEx C and Digene Hybrid Capture II HPV DNA testing.

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens.

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion.

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

HPV mRNA test in women with minor cervical lesions: experience of the University Hospital of North Norway.

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

The 2001 Bethesda System: terminology for reporting results of cervical cytology

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C).

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology.

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

BD-ProExC as Adjunct Molecular Marker for Improved Detection of CIN2+ after HPV Primary Screening

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

21 January 2018

Women >or=30 years of age with low grade squamous intraepithelial lesion (LSIL) have low positivity rates when cotested for high-risk human papillomavirus: should we reconsider HPV triage for LSIL in older women?

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FDC.22944

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DC.22944

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43524242&oldid=2098092826"